The D2 dopamine receptor (DRD2) gene is associated with co-morbid depression, anxiety and social dysfunction in untreated veterans with post-traumatic stress disorder

European Psychiatry

Volumn 21, Issue 3, 2006, Pages 180-185

  Lawford, Bruce R ^a,b   Young, Ross ^b,c   Noble, Ernest P ^b,d   Kann, Burnett ^e   Ritchie, Terry ^b  

^a GREENSLOPES PRIVATE HOSPITAL   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NAMBOUR GENERAL HOSPITAL   (Australia)

Author keywords

Anxiety; Depression; DRD2 polymorphism; PTSD; Social dysfunction

Indexed keywords

DOPAMINE 2 RECEPTOR; RECEPTOR SUBUNIT;

ADULT; ALLELE; ANXIETY DISORDER; ARTICLE; CAUCASIAN; CLUSTER ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; POLYMERASE CHAIN REACTION; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; QUESTIONNAIRE; RECEPTOR GENE; SCORING SYSTEM; SOCIAL DISABILITY; SYMPTOMATOLOGY; VETERAN; ANALYSIS OF VARIANCE; AUSTRALIA; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; MIDDLE AGED; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; SOCIOPATHY;

ALLELES; ANALYSIS OF VARIANCE; ANXIETY DISORDERS; AUSTRALIA; CLUSTER ANALYSIS; COMORBIDITY; DEPRESSIVE DISORDER; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; RECEPTORS, DOPAMINE D2; SEVERITY OF ILLNESS INDEX; SOCIAL BEHAVIOR DISORDERS; STRESS DISORDERS, POST-TRAUMATIC; VETERANS;

EID: 33646063797     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2005.01.006     Document Type: Article

References (49)

1. Ainsworth K., Smith S.E., Zetterstrom T.S., Pei Q., Franklin M., and Sharp T. Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat. Psychopharmacology (Berl.) 140 (1998) 470-477
2. Bartoszyk G.D. Anxiolytic effects of dopamine receptor ligands: I. Involvement of dopamine autoreceptors. Life Sci. 62 (1998) 649-663
3. Berk M. Selective serotonin reuptake inhibitors in mixed anxiety-depression. Int. Clin. Psychopharmacol. 15 Suppl 2 (2000) S41-S45
4. Berman S.M., and Noble E.P. The D2 dopamine receptor (DRD2) gene and family stress; interactive effects on cognitive functions in children. Behav. Genet. 27 (1997) 33-43
5. Bjelland I., and Dahl A.A. Anxiety and depression-a common mixture. Tidsskr. Nor. Laegeforen. 119 (1999) 3277-3280
6. Bouras N., and Bridges P.K. Bromocriptine in depression. Curr. Med. Res. Opin. 8 (1982) 150-153
7. Bressan R.A., Costa D.C., Jones H.M., Ell P.J., and Pilowsky L.S. Typical antipsychotic drugs-D2 receptor occupancy and depressive symptoms in schizophrenia. Schizophr. Res. 56 (2002) 31-36
8. de Haan L., Lavalaye J., Linszen D., Dingemans P.M., and Booij J. Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone. Am. J. Psychiatry 157 (2000) 1019-1020
9. Deahl M.P., Gillham A.B., Thomas J., Searle M.M., and Srinivasin M. Psychological sequelae following the Gulf war. Factors associated with subsequent morbidity and the effectiveness of psychological debriefing. Br. J. Psychiatry 165 (1994) 60-65
10. Dziedzicka-Wasylewska M., Rogoz R., Klimek V., and Maj J. Repeated administration of antidepressant drugs affects the levels of mRNA coding for D1 and D2 dopamine receptors in the rat brain. J. Neural Transm. 10 (1997) 515-524
11. Everitt B.S., Landau S., and Leese M. Cluster analysis (2001), Edward Arnold, London
12. Fuesner J., Ritchie T., Lawford B., Young R.M., Kann B., and Noble E.P. GABA-A beta 3 subunit gene and psychiatric morbidity in a post-traumatic disorder stress population. Psychiatry Res. 104 (2001) 109-117
13. Gingrich B., Liu Y., Cascio C., Wang Z., and Insel T.R. Dopamine D2 receptors in the nucleus accumbens are important for social attachment in female prairie voles (Microtos orchogaster). Behav. Neurosci. 114 (2000) 173-183
14. Grandy D.K., Zhang Y., and Civelli O. PCR detection of the Taq A RFLP at the DRD2 locus. Hum. Mol. Genet. 2 (1993) 2197
15. Hallman W.K., Kipen H.M., Diefenbach M., Boyd K., Kang H., Leventhal H., et al. Symptom patterns among Gulf war registry veterans. Am. J. Public Health 93 (2003) 624-630
16. Hill S.Y., Zezza N., Wipprecht G., Locke E., and Neiswanger K. Personality traits and dopamine receptors (D2 and D4): linkage studies in families of alcoholics. Am. J. Med. Genet. 88 (1999) 634-641
17. Koenen K.C., Harley R., Lyons M.J., Wolfe J., Simpson J.C., Goldberg J., et al. A twin registry study of familial and individual risk factors for trauma exposure and posttraumatic stress disorder. J. Nerv. Ment. Dis. 190 4 (2002) 209-218
18. Jönsson E.G., Nöthen M.M., Grünhage F., Farde L., Nakashima Y., Propping P., et al. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol. Psychiatry 4 (1999) 290-296
19. Kameda K., Kusumi I., Suzuki K., Miura J., Sasaki Y., and Koyama T. Effects of citalopram on dopamine D2 receptor expression in the rat brain striatum. J. Mol. Neurosci. 14 (2000) 77-86
20. Keane T.M., Caddell J.M., and Taylor K.L. Mississippi scale for combat-related post-traumatic stress disorder: three studies in reliability and validity. J. Consult. Clin. Psychol. 56 (1988) 85-90
21. Kestler L.P., Malhotra A.K., Finch C., Adler C., and Breier A. The relation between dopamine D2 receptor density and personality: preliminary evidence from the NEO personality inventory-revised. Neuropsychiatry Neuropsychol. Behav. Neurol. 13 (2000) 48-52
22. Klimek V., Schenck J.E., Han H., Stockmeier C.A., and Ordway G.A. Dopaminergic abnormalities in amygdaloid nuclei in major depression: a post-mortem study. Biol. Psychiatry 52 (2002) 740-748
23. 123I] IBZM SPECT. Psychiatry Res. 90 2 (1999) 91-101
24. Kozaric-Kovacic D., Hercigonja D.K., and Grubisic-Ilic M. Posttraumatic stress disorder and depression in soldiers with combat experiences. Croat. Med. J. 42 2 (2001) 165-170
25. Lawford B.R., Young R., Noble E.P., Kann B., Arnold L., Rowell J., et al. D2 dopamine receptor gene polymorphism: paroxetine and social functioning in post-traumatic stress disorder. Eur. Neuropsychopharmacol. 13 (2003) 313-320
26. Lawford B.R., Young R., Rowell J.A., Qualichefski J., Fletcher B.H., Syndulko K., et al. Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele. Nat. Med. 1 (1995) 337-341
27. Marino C., Vanzin L., Giorda R., Frigerio A., Lorusso M.L., Nobile M., et al. An assessment of transmission disequilibrium between quantitative measures of childhood problem behaviors and DRD2/Taq1 and DRD4/48bp-repeat polymorphisms. Behav. Genet. 34 (2004) 495-502
28. Miller M.W., Greif J.L., and Smith A.A. Multidimensional personality questionnaire profiles of veterans with traumatic combat exposure. Externalizing and Internalizing Subtypes. Psychol. Assess. 15 2 (2003) 205-215
29. Nash M.W., Huezo-Diaz P., Williamson R.J., Sterne A., Purcell S., Hoda F., et al. Genome-wide linkage analysis of a composite index of neuroticism and mood-related scales in extreme selected sibships. Hum. Mol. Genet. 13 (2004) 2173-2182
30. Noble E.P., Blum K., Ritchie T., Montgomery A., and Sheridan P.J. Allelic association of the D2 dopamine receptor gene with receptor binding characteristics in alcoholism. Arch. Gen. Psychiatry 48 (1991) 648-654
31. O'Toole B.I., Marshall R.P., Schureck R.J., and Dobson M. Post-traumatic stress disorder and co-morbidity in Australian Vietnam veterans: risk factors, chronicity and combat. Aust. New Zealand J. Psychiatry 32 (1998) 32-42
32. Ormel J., Koeter M.W., Van der Brink W., and Giel R. Concurrent validity of GHQ-28 and PSE as measures of change. Psychol. Med. 19 (1989) 1007-1013
33. Pania L., and Gessab G.L. Dopaminergic deficit and mood disorders. Int. Clin. Psychopharmacol. Suppl 4 (2002) S1-S7
34. 2 receptor availability in healthy volunteers. Mol. Psychiatry 3 (1998) 256-260
35. Rausch J.L., Hobby H.M., Shendarkar N., Johnson M.E., and Li J. Fluvoxamine treatment of mixed anxiety and depression: evidence for serotonergically medicate anxiolysis. J. Clin. Psychopharmocol. 21 (2001) 139-142
36. Schneier F.R., Blanco C., Antia S.X., and Leibowitz M.R. The social anxiety spectrum. Psychiatr. Clin. North Am. 25 (2002) 757-774
37. Schneier F.R., Leibowitz M.R., Abi-Dargham A., Zea-Ponce Y., Lyn S.H., and Laurelle M. Low dopamine D(2) receptor binding potential in social phobia. Am. J. Psychiatry 158 (2001) 327-328
38. Shively C.A., Grant K.A., Ehrenkaufer R.L., Mach R.H., and Nader M.A. Social stress, depression and brain dopamine in female cynomolgus monkeys. Ann. New York Acad. Sci. 807 (1997) 574-577
39. Stein M.B., Jang K.L., Taylor S., Vernon P.A., and Livesley W.J. Genetic and environmental influences on trauma exposure and post-traumatic stress disorder symptoms: a twin study. Am. J. Psychiatry 159 (2002) 1675-1681
40. Theohar C., Fischer-Comelssen K., Brosch H., Fischer E.K., and Petroic D. A comparative, multicenter trial between bromocriptine and amitriptyline in the treatment of endogenous depression. Arzneimittelforschung 32 (1982) 783-787
41. Thompson J., Thomas N., Singleton A., Piggott M., Lloyd S., Perry E.K., et al. D2 dopamine receptor gene (DRD2) TaqI A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 7 (1997) 479-484
42. Tremblay L.K., Naranjo C.A., Cardenas L., Herrmann N., and Busto U.E. 2002. Probing brain reward system function in major depressive disorder: altered response to dextroamphetamine. Arch. Gen. Psychiatry 59 (2002) 409-416
43. True W.R., Rice J., Eisen S.A., Heath A.C., Goldberg J., Lyons M.J., et al. A twin study of genetic and environmental contributions to liability for post-traumatic stress symptoms. Arch. Gen. Psychiatry 50 (1993) 257-264
44. 2 receptor levels. Am. J. Psychiatry 156 (1999) 1440-1443
45. Volkow N.D., Wang G.-J., Fowler J.S., Thanos T., Logan J., Gatley S.J., et al. Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study. Synapse 46 (2002) 79-82
46. Waehrens J., and Gerlach J. Bromocriptine and imipramine in endogenous depression: a double-blind controlled trial in outpatients. J. Affect. Disord. 3 (1981) 193-202
47. Ward W. Psychiatric morbidity in Australian veterans of the United Nations peacekeeping force in Somalia. Aust. New Zealand J. Psychiatry 31 (1997) 184-193
48. Young R.M., Lawford B.R., Nutting A., and Noble E.P. Advances in molecular genetics and the prevention and treatment of substance misuse: implications of association studies of the A1 allele of the D2 dopamine receptor genes. Addict. Behav. 29 (2004) 1275-1294
49. Zatzick D.F., Marmar C.R., Weiss D.S., Browner W.S., Metzler T.J., Golding J.M., et al. Post-traumatic stress disorder and quality of life outcomes in a nationally representative sample of male Vietnam veterans. Am. J. Psychiatry 154 (1997) 1690-1695